Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial by Ellis, Peter M, Dr, Shepherd, Frances A, Prof, Millward, Michael, Prof, Perrone, Francesco, PhD, Seymour, Lesley, Prof, Liu, Geoffrey, MD, Sun, Sophie, MD, Cho, Byoung Chul, MD, Morabito, Alessandro, MD, Leighl, Natasha B, MD, Stockler, Martin R, Prof, Lee, Christopher W, MD, Wierzbicki, Rafal, MD, Cohen, Victor, MD, Blais, Normand, MSc, Sangha, Randeep S, MD, Favaretto, Adolfo G, MD, Kang, Jin Hyoung, MD, Tsao, Ming-Sound, Prof, Wilson, Carolyn F, MSc, Goldberg, Zelanna, MD, Ding, Keyue, PhD, Goss, Glenwood D, Prof, Bradbury, Penelope Ann, MBBCh

Get full text

Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial by Cho, B C John, MD, Donahoe, Laura, MD, Bradbury, Penelope A, MD, Leighl, Natasha, Prof, Keshavjee, Shaf, Prof, Hope, Andrew, MD, Pal, Prodipto, MD, Cabanero, Michael, MD, Czarnecka, Kasia, MD, McRae, Karen, MD, Tsao, Ming-Sound, Prof, de Perrot, Marc, Prof

Get full text

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol by Redman, Mary W, Prof, Papadimitrakopoulou, Vassiliki A, Prof, Minichiello, Katherine, MS, Hirsch, Fred R, Prof, Mack, Philip C, PhD, Schwartz, Lawrence H, Prof, Vokes, Everett, Prof, Ramalingam, Suresh, Prof, Leighl, Natasha, MD, Bradley, Jeff, Prof, Miao, Jieling, MS, Moon, James, MS, Highleyman, Louise, BS, Miwa, Crystal, BS, LeBlanc, Michael L, Prof, Malik, Shakun, MD, Miller, Vincent A, MD, Sigal, Ellen V, PhD, Adam, Stacey, PhD, Wholley, David, MS, Sigman, Caroline, PhD, Smolich, Beverly, PhD, Blanke, Charles D, Prof, Kelly, Karen, Prof, Gandara, David R, Prof, Herbst, Roy S, Prof

Get full text